KCNJ8 and hypertrichotic osteochondrodysplasia Cantu type: This observation strongly suggests that a specific inhibitor of Kir6.1/SUR2B may offer new therapeutic opportunities for treating PDA and potentially other cardiovascular complications observed in Cantu syndrome.